公司资料

HOOKIPA Pharma Inc. 股价、新闻与催化剂

股票代码:: HOOK
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股票表现

1.15 USD (+0.88%)

收盘价

最后更新: 2026年6月2日

—

市值

股价为何变动

Current closing-price context is not available for HOOK.

公司概览

业务概览

Hookipa Pharma is a biopharmaceutical company focused on immunotherapy and oncology, with a strategy that has centered on viral-vector and immune-based platforms. Its business has been shaped by platform ambition and strategic resets.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, Hookipa sits in specialty biotechnology.

商业模式特征

The company depends on clinical validation, partnerships, and the ability to find a durable immune-therapy franchise.

生物医药行业定位

Hookipa is a high-risk immunology name whose story depends heavily on platform and financing progress.

未来催化剂

HOOKIPA’s catalysts are HB-700 and the rest of its viro-immunotherapy platform, plus any partnership or strategic update. The market will care about whether the viral-immunotherapy thesis still has a path.